stockrowAdaptive Biotechnologies Corporation (ADPT) vs CareDx, Inc. (CDNA)
- Adaptive Biotechnologies Corporation ADPT 27.17 +1.27%
- CareDx, Inc. CDNA 78.30 +2.58%
Adaptive Biotechnologies Corporation and CareDx, Inc. are both Diagnostics & Research companies. Adaptive Biotechnologies Corporation and CareDx, Inc. are of similar size ($4.3B and $4.0B). Adaptive Biotechnologies Corporation has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 30.9×. CareDx, Inc. grew revenue faster over the last twelve months: 38.9% against 17.9%. CareDx, Inc. has the higher net margin (25.9% vs −23.7%) and the higher return on invested capital (33.6% vs 0.00%). Across the 17 metrics below, CareDx, Inc. leads on 12 and Adaptive Biotechnologies Corporation on 5.
Valuation
Profitability
| Metric | ADPT | CDNA | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 74.15% | 70.97% | 48.32% |
| Operating margin | (16.18%) | 23.42% | (5.68%) |
| Net margin | (23.66%) | 25.86% | (4.10%) |
| Free cash flow margin | (2.96%) | 12.01% | 0.00% |
| Return on equity | (36.34%) | 33.04% | 0.00% |
| Return on assets | (12.02%) | 23.96% | (6.05%) |
| Return on invested capital | 0.00% | 33.56% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack